RCS - Nando - Biotech Pioneer Nando Embarks on Global Expansion

Skandinaviska Enskilda Banken ABAnnouncement

07/05/2024 08:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240507:nRSG2983Na&default-theme=true

RNS Number : 2983N  Nando  07 May 2024

Lithuanian Biotech Pioneer 'Nando' Embarks on Global Expansion With New
Management Team and Innovative Production Line

"Nando", a leading Lithuanian-owned biotechnology company known for its
groundbreaking work in developing microbiological products for agriculture,
that helped to save up to 50M on fertilisers, announces a significant
bolstering of its management team and an ambitious expansion of its
biotechnological production line. This move is set to position "Nando" not
just as a leader in Lithuania but as a formidable player on the international
stage.

KAUNAS, LITHUANIA / ACCESSWIRE / May 7, 2024 / In a strategic enhancement of
its management team, "Nando
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly93d3cubmFuZG8ubHQ&sig=1sEp6SP0LTC-KNMonfTYKppJvIMt4QiX3yIakKxySD-yNe1Bqmdc85orsCMZFrubV6vPl5Vp79Cii2nEMByVZw&hit%2Csum=WyI0YjJjNDgiLCI0YjJjNDkiLCI0YjJjNGEiXQ)
" welcomes four seasoned professionals, each bringing a wealth of experience
from reputable organizations. Gytis Kubilius, with a solid background in
management at "SEB" and "Citadele" banks; Mindaugas Navickas, previously
International Sales Manager at "Teltonika Networks"; Arūnas Jusas, former
General Manager at "Timac AGRO"; and Giedrė Mockienė, who served as HR
Manager at UAB "Yara", are now integral parts of "Nando's" leadership, aiming
to spearhead ambitious development projects.

To cater to the surging demand for microbiological alternatives to mineral
fertilizers and plant protection products, "Nando" has invested about €3
million in a unique biotechnology line
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly9uYW5kb2Jpb3RlY2guY29tLw&sig=NAl_fthUMy-pzst4GTz84kciG4cek_rBIm318ZWwr1QUmhNS1HUq94juUirKGA_ugWyP-LytSunW5hIinr6FPw&hit%2Csum=WyI0YjJjNGIiLCI0YjJjNGMiLCI0YjJjNGEiXQ)
. This investment boosts production volume, enhances productivity, and ensures
competitive pricing to meet the escalating market demand. With a technology
that is currently patent-pending, "Nando" exports to over 20 countries,
including Great Britain, Ukraine, Estonia, Kazakhstan, Latvia, Poland, Romania
and beyond.

Justinas Taruška
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly93d3cubGlua2VkaW4uY29tL2luL3RhcnVza2Ev&sig=6tmJ7gDyob8FnnEIKQFvsLybx9PF42Ce6HcGPwoKu-c1iRE21Z326JbG2p8PElofIad0d1Lh-z20TNVW9uHMDQ&hit%2Csum=WyI0YjJjNGQiLCI0YjJjNGUiLCI0YjJjNGEiXQ)
, CEO of "Nando", stated, "Our main goal is to feature a highly automated
biotechnological production line. This will not only elevate the
agro-biotechnology sector's value in Lithuania but also accelerate sustainable
and economically viable agricultural technologies across Europe and other
continents." The new production line is renowned for its unique microorganism
purification technology, a rarity in the entire Baltic region. It promises an
efficient production of stable, high-yield microbiological products in powder
form, a technology with limited competition.

The inclusion of new management members, with their extensive international
experience, underscores "Nando's" commitment to employee development and its
focus on penetrating foreign markets, including Europe, North and South
America, Asian and Africa countries. This strategic move coincides with the
launch of the new production line for microbiological products.

Founded in 2007, "Nando" stands at the forefront of the biotech industry,
developing and manufacturing microbiological products and chemical additives
for agriculture
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly93d3cubmFuZG8ubHQvZW4vY2F0ZWdvcnkvcmVzZWFyY2gtYW5kLXRlY2hub2xvZ3k&sig=vmsKZS6VDphSBdR6_K3_VmlHO15VwITLGi8dipWPy_jxionrx3KvwuDOwEZI6XgjjG514OXUr1Dl7Yj5kIFOFA&hit%2Csum=WyI0YjJjNGYiLCI0YjJjNGciLCI0YjJjNGEiXQ)
. With one of Northern Europe's leading R&D centers
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly93d3cubmFuZG8ubHQvZW4vbGFib3JhdG9yeS1yZXNlYXJjaA&sig=H1R9T95gNgcI8ZuiHbNtQbT3y49JGUNeaZmHCCGUBkNPYuWE20vkY3IDdQICXGLaF2KJCnmDOCjon5V0TinRTQ&hit%2Csum=WyI0YjJjNGgiLCI0YjJjNGkiLCI0YjJjNGEiXQ)
and partnerships with global research institutions, "Nando" has introduced
over 50 innovative products, vital to the agro, livestock. Currently, the
company is intensifying its export activities, with operations spanning over
20 countries in Europe, North and South America, Asian and Africa. The "Nando
Group" proudly employs more than 50 professionals dedicated to advancing
global biotechnology solutions.

Contact Information:

Milda Gauliene

Marketing specialist
milda@nando.lt (mailto:milda@nando.lt)

+37066475297

 

View the original press release
(https://www.newswire.com/news/lithuanian-biotech-pioneer-nando-embarks-on-global-expansion-with-new-22323385)
on newswire.com.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAZQLFBZELLBBB